Led by former BioNTech executives, Bambusa Therapeutics (BBTX.US) races toward Nasdaq to fund eczema drug trials.

Zhitong Finance APP has learned that Bambusa Therapeutics Inc. (BBTX.US) has submitted an initial public offering application, planning to raise funds for clinical trials to develop treatments for eczema and other inflammatory diseases.